stop use immediately Recalls

B. Braun Medical Blood Administration Set Recall 7,344 Units Over Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical Blood Administration Set Recall 2025 for 24,624 Units Worldwide

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

Philips Incisive CT Recall 2025: 2,341 CT Scanners Over Loose Tube Heat Exchanger Screws

B. Braun Medical 490238 Extension Set Recalled for IV Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical IV Administration Set Recall: 5,100 Units Distributed Worldwide Over Backflow and Oc

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

BBMI IV Administration Sets Recalled in 2025 for Backflow and Occlusion Risk, 20.7 Million Units

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical SAFELINE IV Sets Recalled for 46,250 Units Over Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical Blood Administration Set Recall 33,528 Units for Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical Infusomat IV Sets Recalled for Backflow and Occlusion Risk (49,330,370 Units)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical Recalls 3,120 IV Administration Sets for Infusomat Pumps in 2025

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set Recall 66,792 Units for Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set Recall 122,232 Units Over Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set Recall for 45,288 Units Over Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical IV Administration Set Recall 36,936 Units for Backflow and Occlusion Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical Recalls 12,168 IV Administration Sets for Backflow and Occlusion Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical Recalls 98,568 IV Administration Sets for Backflow and Occlusion Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set Recall for 5,952 Units Over Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set Recall 2025 Affects 259,392 Units

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical Recalls 12,200 IV Administration Sets for Backflow and Occlusion Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set Recall for 1,250 Units Over Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).